













OrganXpert
Clinical Trial Alternative Cell Culture Platform
Biospero
OrganXpert significantly advances medical development by overcoming traditional clinical trial limitations and presenting a new paradigm. It enables direct experimentation on selectively cultured human cells, aiming to replace clinical trials. The OrganXpert creates an optimal environment for stem cells, supported by surrounding products. It can culture 12 cell culture chips simultaneously, making it fast and economical. The integrated recirculating flow module mimics human fluid flow, allowing for tissue modeling. The design focuses on usability, featuring a one-touch cartridge detachment and a simplified interface for intuitive operation.
Client / ManufacturerDesign
Biospero
Jeju island, KR
Via Collective
Seoul, KRHankak Lee, Seungsu Mok, Hayoung LeeDate of Launch
2025
Development Time
up to 24 Month
Target Regions
North America
Target Groups
"University / University Hospital / Laboratory / Pharmaceutical Company / CRO"